Mounjaro Injection: A Dual-Action Weight Loss Solution
Mounjaro (tirzepatide) is a groundbreaking weekly injection approved in the UK for weight management in adults with obesity or overweight conditions linked to health issues like type 2 diabetes, high blood pressure, or high cholesterol. Unlike other treatments, Mounjaro injection targets both GLP-1 and GIP receptors, enhancing appetite suppression and improving blood sugar control. Clinical trials have demonstrated significant weight loss, with some patients shedding up to 22.5% of their body weight. It's administered via a pre-filled pen, starting at 2.5 mg weekly and gradually increasing to a maximum of 15 mg. Common side effects include nausea, vomiting, and digestive issues, which often subside over time. Mounjaro is available through NHS specialist weight management services and private clinics across the UK.